Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas

Commun Biol. 2023 Jun 20;6(1):653. doi: 10.1038/s42003-023-05035-2.

Abstract

The extracellular microenvironment modulates glioma behaviour. It remains unknown if blood-brain barrier disruption merely reflects or functionally supports glioma aggressiveness. We utilised intra-operative microdialysis to sample the extracellular metabolome of radiographically diverse regions of gliomas and evaluated the global extracellular metabolome via ultra-performance liquid chromatography tandem mass spectrometry. Among 162 named metabolites, guanidinoacetate (GAA) was 126.32x higher in enhancing tumour than in adjacent brain. 48 additional metabolites were 2.05-10.18x more abundant in enhancing tumour than brain. With exception of GAA, and 2-hydroxyglutarate in IDH-mutant gliomas, differences between non-enhancing tumour and brain microdialysate were modest and less consistent. The enhancing, but not the non-enhancing glioma metabolome, was significantly enriched for plasma-associated metabolites largely comprising amino acids and carnitines. Our findings suggest that metabolite diffusion through a disrupted blood-brain barrier may largely define the enhancing extracellular glioma metabolome. Future studies will determine how the altered extracellular metabolome impacts glioma behaviour.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Blood-Brain Barrier / metabolism
  • Brain / metabolism
  • Brain Neoplasms* / metabolism
  • Glioma* / metabolism
  • Humans
  • Metabolome
  • Tumor Microenvironment